Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy
Publisher: John Wiley & Sons Inc
E-ISSN: 1872-034x|45|8|872-879
ISSN: 1386-6346
Source: HEPATOLOGY RESEARCH, Vol.45, Iss.8, 2015-08, pp. : 872-879
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract